Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)
-
- Tohru Kobayashi
- Department of Management and Strategy National Center for Child Health and Development Setagaya‐ku Japan
-
- Mamoru Ayusawa
- Department of Pediatrics and Child Health Nihon University Itabashi‐ku Japan
-
- Hiroyuki Suzuki
- Department of Pediatrics Wakayama Medical University Wakayama Japan
-
- Jun Abe
- Division of Advanced Medicine for Virus Infections Research Institute National Research Institute for Child Health and Development Tokyo Japan
-
- Shuichi Ito
- Pediatrics Yokohama City University Graduate School of Medicine Yokohama Japan
-
- Taichi Kato
- Pediatrics/Developmental Pediatrics Nagoya University Graduate School of Medicine Nagoya Japan
-
- Masahiro Kamada
- Pediatric Cardiology Hiroshima City Hiroshima Citizens Hospital Hiroshima Japan
-
- Junko Shiono
- Pediatric Cardiology Ibaraki Children's Hospital Mito Japan
-
- Kenji Suda
- Pediatrics and Child Health Kurume University School of Medicine Kurume Japan
-
- Keiji Tsuchiya
- Department of Pediatrics Japanese Red Cross Medical Center Tokyo Japan
-
- Tsuneyuki Nakamura
- Pediatrics Tsune Family Clinic Kanazawa Japan
-
- Yoshikazu Nakamura
- Public Health Jichi Medical University Shimotsuke Japan
-
- Yuichi Nomura
- Pediatrics Kagoshima City Hospital Kagoshima Japan
-
- Hiromichi Hamada
- Pediatrics Tokyo Women's Medical University Yachiyo Medical Center Yachiyo Japan
-
- Ryuji Fukazawa
- Pediatrics Nippon Medical School Tama City Japan
-
- Kenji Furuno
- Kawasaki Disease Center Fukuoka Children's Hospital Fukuoka Japan
-
- Hiroyuki Matsuura
- Departments of Pediatrics Toho University School of Medicine Tokyo Japan
-
- Tomoyo Matsubara
- Pediatrics Dokkyo Medical University Saitama Medical Center Koshigaya Japan
-
- Masaru Miura
- Cardiology Tokyo Metropolitan Children's Medical Center Tokyo Japan
-
- Kei Takahashi
- Pathology Toho University School of Medicine Tokyo Japan
この論文をさがす
説明
Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.
収録刊行物
-
- Pediatrics International
-
Pediatrics International 62 (10), 1135-1138, 2020-10
Wiley
